Spruce Street Capital LP: KALVISTA PHARMACEUTICALS (KALV): Quarterly 13F Position History
As of Q1 2026, Spruce Street Capital LP reported 897,681 shares of KALVISTA PHARMACEUTICALS (KALV), worth $18.1M and representing 4.3% of its 13F equity book. Quarter-over-quarter share count change: + 509,713 (+131.4%) . The position first appeared in Q4 2025 and has been disclosed across 2 13F-HR filings in Pactolio's tracked window.
- 897,681Shares Held (Latest Filing)
- $18.1MReported Market Value (Latest Filing)
- 4.3%Portfolio Weight (% of 13F Equity Book)
- +509,713Quarter-over-Quarter Share Change
- +$11.8MQuarter-over-Quarter Value Change
- 897,681Peak Reported Shares (Historical)
Recent initiation: Spruce Street Capital LP first reported KALV on the Q4 2025 filing — fewer than three quarters of history are available.
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 897,681 | +509,713 | +131.4% | $18.1M | 4.3% | $20.1 |
| Q4 2025 | 387,968 | — | — | $6.3M | 2.1% | $16.1 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Spruce Street Capital LP first disclose a KALV position in 13F-HR filings?
Spruce Street Capital LP first reported KALVISTA PHARMACEUTICALS (KALV) on its 13F-HR filing for the period ending 2025-12-31 (Q4 2025). The position has appeared on 2 reported quarters within Pactolio's tracked window.
What was Spruce Street Capital LP's most recent quarter-over-quarter share-count change in KALV?
Between Q4 2025 and Q1 2026, Spruce Street Capital LP added 509,713 shares of KALV (+131.4%), bringing the total reported position to 897,681 shares at a market value of $18.1M.
Does the implied price-per-share represent Spruce Street Capital LP's cost basis in KALV?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.